<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03693365</url>
  </required_header>
  <id_info>
    <org_study_id>291917072018</org_study_id>
    <nct_id>NCT03693365</nct_id>
  </id_info>
  <brief_title>Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial</brief_title>
  <official_title>The Reliability of Noninvasive Effective Pulmonary Blood Flow to Detect Fluid Responsiveness During a Positive End-expirator Trial in Ventilated Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Privado de Comunidad de Mar del Plata</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Privado de Comunidad de Mar del Plata</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fluid responsiveness is difficult to assess at the bedside. The accuracy of published
      techniques to detect preload-dependent patients have many pitfalls and limitations. The
      present study test the role of noninvasive effective pulmonary blood flow measured by expired
      carbon dioxide to detect fluid responsivess in mechanically ventilated patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective and observational study designed to test the accuracy of the
      non-invasive effective pulmonary blood flow measured by the capnodynamic methodology for
      detect preload-dependent patients.

      Fourty patients undergoing mechanical ventilation during surgery will be studied.
      Preload-depency (fluid responsiveness) will be tested during an increase in end-expiratory
      pressure (PEEP) from 5 to 10 cmH2O during one minute. Pulse pressure variation will be use as
      the reference method to detect preload-dependency. The effective pulmonary blood flow will be
      continuously recorded during the PEEP maneuver. Receiver Operator Curves will be used to
      detect fluid responsiveness taking a pulse pressure variation higher than 13%.The
      corresponding cut off value for the effective pulmonary blood flow signal will be
      determined..
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 5, 2018</start_date>
  <completion_date type="Anticipated">August 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fluid responsivess assessment with the effective pulmonary blood flow</measure>
    <time_frame>10 months</time_frame>
    <description>Comparison between standard method (pulse pressure variation) with a new method of fluid responsiveness (Effective pulmonary blood flow).</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>Patients undergoing surgeries</arm_group_label>
    <description>Patients undergoing surgery with general anesthesia and controlled mechanical ventilation with indication of invasive arterial blood pressure.
Classification ASA 2-4</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PEEP trial</intervention_name>
    <description>Positive end-expiratory pressure (PEEP) is increased from 5 to 10 cmH2O during one minute.</description>
    <arm_group_label>Patients undergoing surgeries</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Cardiac and noncardiac surgery patients ASA 2-4
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent

          -  Programmed cardiac and noncardiac surgeries

          -  Need of invasive arterial blood pressure monitoring.

        Exclusion Criteria:

          -  Emergency surgeries.

          -  Acute pulmonary diseases

          -  Arrhytmias

          -  Congestive cardiac failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerardo Tusman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Privado de Comunidad de Mar del Plata</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cecilia M Acosta, MD</last_name>
    <phone>542234990074</phone>
    <email>ceciliamacosta@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Esteban GÃ¡ndara, MD</last_name>
    <phone>542234990099</phone>
    <email>gandara.esteban@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Privado de Comunidad</name>
      <address>
        <city>Mar del Plata</city>
        <state>Buenos Aires</state>
        <zip>7600</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <results_reference>
    <citation>Tusman G, Groisman I, Maidana GA, Scandurra A, Arca JM, Bohm SH, Suarez-Sipmann F. The Sensitivity and Specificity of Pulmonary Carbon Dioxide Elimination for Noninvasive Assessment of Fluid Responsiveness. Anesth Analg. 2016 May;122(5):1404-11. doi: 10.1213/ANE.0000000000001047.</citation>
    <PMID>26505574</PMID>
  </results_reference>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>October 1, 2018</study_first_submitted>
  <study_first_submitted_qc>October 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 3, 2018</study_first_posted>
  <last_update_submitted>February 12, 2020</last_update_submitted>
  <last_update_submitted_qc>February 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Carbon dioxide</keyword>
  <keyword>Pulmonary blood flow</keyword>
  <keyword>Ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

